Alforex News

Alflorex® Wins Best Gastrointestinal Product Award

Alflorex® has won the best Gastrointestinal product for the second year running in the highly regarded Irish Pharmacy News (IPN) Awards 2017.  These awards acknowledge the innovation, dedication, and achievements from some of the leading companies in the pharmacy sector.

Alflorex® has previously attained the ‘Best Irish Pharmacy Product’ in 2015, the ‘Best Natural Product’ and the ‘Best GI (Gastrointestinal) Product’ in 2016. A successful third year of accolades was achieved by the brand against strong competition. The product was named the ‘Best GI (Gastrointestinal) Product’, for the second year running for 2017.  If you would like more information on Alflorex® please visit the website

About Alimentary Health.

Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary bacterial and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the APC Microbiome Institute based at University College Cork, Ireland.

AH’s mission is to develop clinically supported microbiome based healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of unique bacterial strains and their actives for inflammatory and infectious conditions, reflecting our expertise in gastrointestinal medicine, the brain-gut axis, metabolic health and nutrition.  If you would like to learn more about Alimentary Health, please visit the website

Recent Articles

Susan Trent Photo

Atlantic Therapeutics appoints Susan Trent as new CEO, based in the United States.

Galway, Ireland.   Seroba’s portfolio company, Atlantic Therapeutics, a Galway-based MedTech and Femtech innovator, announces a transition in leadership to fulfill […]

Read More
Cancer Killers

Fusion Pharmaceuticals Announces Pricing of Initial Public Offering.

HAMILTON, ONTARIO and Boston. 25 June 2020.  Fusion Pharmaceuticals Inc. (NASDAQ: FUSN), a clinical-stage oncology company focused on developing next-generation […]

Read More
Alflorex Zenflore V2

Novozymes acquires PrecisionBiotics Group.

25 June 2020.  Seroba’s portfolio company, PrecisionBiotics Group has been acquired by Novozymes. Based in Cork, Ireland, PrecisionBiotics Group holds […]

Read More
The Big Taboo

New U.K. Study Offers Good News to Sufferers During World Continence Week

A new study has been published in the Journal of Medical Economics demonstrating that INNOVO® is a compelling and cost-effective […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top